In Denmark, all types of insulin as well as devices and technologies for blood glucose monitoring and insulin administration are available for free for people living with diabetes (PwD) meeting the national guidelines. Since 2016, an annual co-payment has been introduced for reimbursable prescription medicines, amounting to EUR 600 in 2023.

Real-time and intermittently scanned continuous glucose monitors (CGMs), insulin pumps, automated delivery systems and connected smart pens are available for people living with Type 1 Diabetes. Intermittently scanned CGMs are set to be also reimbursed for people living with Type 2 Diabetes starting from 2025.

Diabetes education is provided at the time of diagnosis and throughout the life course. In some regions, peer support is integrated in the education provided.

This country profile was developed with the help of the Danish Diabetes Association (Diabetesforeningen)